Millennium Medical Publishing, Inc

SHERPA: Unknown

People

  1. Tuttle
    Tuttle
  2. Riely
    Riely

Groups

  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (4)
  3. Adult Leukemia (2)
  4. Center for Hematologic Malignancies (2)
  5. Division of Subspecialty Medicine (2)
  6. Endocrinology (2)
  7. GSK Faculty (2)
  8. Hematologic Malignancies Research (2)
  9. Survivorship Research (2)
  10. Solid Tumor Oncology Division (1)
Search Within
  1. "2016"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (4)
  3. Adult Leukemia (2)
  4. Center for Hematologic Malignancies (2)
  5. Division of Subspecialty Medicine (2)
  6. Endocrinology (2)

More Groups

People
  1. Renier Brentjens (2)
  2. Robert Tuttle (2)
  3. Craig Moskowitz (1)
  4. Dan Douer (1)
  5. Daniel McFarland (1)
  6. Gregory Riely (1)

More People

Years
  1. 2016 (9)
Publications
  1. Clinical Advances in Hematology & Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial treatment of progressive differentiated thyroid cancer
    Journal Article

    Tuttle, R. M.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Best use of the tyrosine kinase inhibitors in progressive differentiated thyroid cancer: Discussion
    Journal Article

    Tuttle, R. M.; Brose, M. S.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Novel approaches for the interim management of relapsed/refractory acute lymphocytic leukemia: A case-study compendium
    Journal Article

    Wang, E. S.; Jabbour, E. J.; Douer, D.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • The management of psychological issues in oncology
    Journal Article

    McFarland, D. C.; Holland, J. C.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • CD19-targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Brentjens, R. J.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma [interview]
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Checkpoint inhibitors in breast cancer: Hype or promise? [interview]
    Journal Article

    McArthur, H. L.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Counterpoints: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations?—No, EGFR TKIs should be reserved for patients with EGFR mutations
    Journal Article

    Riely, G. J.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Are chimeric antigen receptor T cells ready for prime time?
    Journal Article

    Brentjens, R. J.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save

    • Millennium Medical Publishing, Inc – authorized name for: